Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17123866 | NEW CANNABIS TABLET FORMULATIONS AND COMPOSITIONS AND METHODS OF MAKING THE SAME | December 2020 | June 2022 | Abandon | 18 | 3 | 0 | Yes | No |
| 17123307 | System and Method for Antibiotic Delivery Using Single-Walled Carbon Nanotubes | December 2020 | June 2024 | Abandon | 42 | 3 | 0 | No | No |
| 17122072 | VASOPROTECTIVE AND CARDIOPROTECTIVE ANTIDIABETIC THERAPY | December 2020 | October 2023 | Allow | 34 | 1 | 1 | No | No |
| 17252532 | HYDROGEL COMPOSITION COMPRISING A CROSSLINKED POLYMER | December 2020 | May 2024 | Allow | 41 | 1 | 1 | No | No |
| 17120507 | ANTIMICROBIAL COLLOIDAL SILVER PRODUCTS AND METHOD OF MAKING SAME | December 2020 | October 2023 | Abandon | 34 | 1 | 0 | No | No |
| 17111873 | PROCESS FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS | December 2020 | May 2022 | Abandon | 18 | 2 | 1 | No | No |
| 17101536 | AVOIDING GAG REFLEX TO ENABLE SWALLOWING PILLS | November 2020 | September 2021 | Allow | 10 | 0 | 0 | No | No |
| 17057103 | PATCH FOR ALLEVIATION AND PREVENTION OF ACNE | November 2020 | March 2023 | Allow | 27 | 3 | 0 | Yes | No |
| 16952209 | METHODS AND POLYMER COMPOSITIONS FOR TREATING RETINAL DETACHMENT AND OTHER OCULAR DISORDERS | November 2020 | January 2023 | Abandon | 26 | 4 | 0 | No | No |
| 16952211 | METHODS AND POLYMER COMPOSITIONS FOR TREATING RETINAL DETACHMENT AND OTHER OCULAR DISORDERS | November 2020 | January 2021 | Allow | 2 | 0 | 0 | Yes | No |
| 16952214 | METHODS AND POLYMER COMPOSITIONS FOR TREATING RETINAL DETACHMENT AND OTHER OCULAR DISORDERS | November 2020 | January 2021 | Allow | 2 | 0 | 0 | Yes | No |
| 17050135 | TOPICAL PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ANAL FISSURES AND HEMORRHOIDS | October 2020 | April 2023 | Allow | 29 | 2 | 0 | No | No |
| 17063491 | BISMUTH-THIOLS AS ANTISEPTICS FOR EPITHELIAL TISSUES, ACUTE AND CHRONIC WOUNDS, BACTERIAL BIOFILMS AND OTHER INDICATIONS | October 2020 | September 2022 | Allow | 24 | 1 | 0 | No | No |
| 17060551 | BIOIDENTICAL PROGESTERONE CREAM INFUSED WITH NANOEMULSIFIED CBD | October 2020 | September 2023 | Abandon | 35 | 1 | 1 | No | No |
| 17028319 | TOPICAL THERAPY FOR THE TREATMENT OF SKIN MALIGNANCIES USING NANOPARTICLES OF TAXANES | September 2020 | September 2021 | Allow | 12 | 0 | 0 | Yes | No |
| 17024268 | WET-PACKED SOFT HYDROGEL OCULAR INSERTS | September 2020 | September 2023 | Allow | 36 | 3 | 0 | No | Yes |
| 17018865 | OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE | September 2020 | July 2022 | Allow | 23 | 2 | 0 | No | No |
| 16980377 | TRANSDERMAL AND/OR DERMAL DELIVERY OF LIPOPHILIC ACTIVE AGENTS | September 2020 | November 2023 | Abandon | 38 | 1 | 1 | No | No |
| 17002399 | POWDER FOR ACHIEVING HEMOSTASIS | August 2020 | March 2023 | Allow | 30 | 1 | 0 | No | No |
| 16988077 | MORINGA OLEIFERA NANOPARTICLES | August 2020 | May 2021 | Allow | 9 | 0 | 0 | Yes | No |
| 16986627 | ANTIBACTERIAL AND DEODORIZING LEATHER | August 2020 | September 2022 | Allow | 25 | 2 | 0 | No | No |
| 16967672 | Compositions and Methods for the Removal of Extraneous Calcium Hydroxyapatite | August 2020 | January 2022 | Abandon | 17 | 1 | 0 | No | No |
| 16965335 | Compositions For Treating And/Or Preventing Photodynamic Therapy Side Effects | July 2020 | April 2023 | Abandon | 33 | 3 | 0 | Yes | No |
| 16965353 | Therapeutic Compositions for Enhanced Healing of Wounds and Scars | July 2020 | July 2023 | Allow | 35 | 3 | 0 | Yes | No |
| 16962948 | COMPOSITIONS FOR THE TREATMENT OF A DISEASE OF THE URINARY TRACT AND TREATMENT OF A DISEASE INVOLVING THE INTRACELLULAR DELIVERY OF THE PARTICLE OR A MEDICAMENT CONTAINED THEREIN | July 2020 | November 2023 | Abandon | 40 | 2 | 1 | No | No |
| 16961017 | PALONOSETRON FOR THE TREATMENT OR PREVENTION OF NAUSEA AND VOMITING | July 2020 | June 2022 | Allow | 24 | 2 | 0 | No | No |
| 16923207 | ANTIMICROBIAL FABRIC TREATMENT | July 2020 | December 2021 | Abandon | 17 | 2 | 0 | No | No |
| 16921628 | PHARMACEUTICAL FORMULATION | July 2020 | February 2022 | Allow | 19 | 1 | 0 | No | No |
| 16960077 | TREATMENT OF MYOPIC PROGRESSION | July 2020 | August 2022 | Allow | 25 | 2 | 0 | No | No |
| 16914230 | ENHANCING AAV-MEDIATED TRANSDUCTION OF OCULAR TISSUES WITH HYALURONIC ACID | June 2020 | June 2021 | Allow | 11 | 2 | 0 | Yes | No |
| 16899699 | Methods and Compositions For Improving Outcomes of Cancer Patients | June 2020 | June 2023 | Abandon | 36 | 2 | 1 | No | Yes |
| 16897758 | STORAGE-STABLE SOLID PEROXYMONOSULFATE COMPOSITION | June 2020 | September 2021 | Allow | 15 | 2 | 0 | Yes | No |
| 16897308 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF ACNE | June 2020 | August 2022 | Abandon | 27 | 4 | 0 | No | No |
| 16892157 | ORALLY ADMINISTRABLE COMPOSITIONS COMPRISING CALCIUM | June 2020 | April 2023 | Abandon | 34 | 1 | 0 | No | No |
| 16878816 | 24-karat Edible Gold Glitter Lipscrub | May 2020 | March 2022 | Abandon | 22 | 1 | 0 | No | No |
| 16866160 | WOUND DEBRIDEMENT COMPOSITION AND METHOD FOR TREATING WOUNDS | May 2020 | June 2022 | Abandon | 25 | 2 | 0 | Yes | No |
| 16849057 | COMPOSITION FOR AMELIORATING POST-CEREBRAL STROKE SEQUELA | April 2020 | May 2024 | Abandon | 49 | 6 | 0 | No | No |
| 16841937 | TREATMENT OF MIGRAINE | April 2020 | July 2022 | Allow | 27 | 4 | 0 | Yes | Yes |
| 16838870 | METHOD FOR EXTENDING TIME OF ACTIVITY OF CHLORITE-BASED BIOCIDES | April 2020 | October 2022 | Allow | 31 | 5 | 0 | No | No |
| 16835921 | PHARMACEUTICAL COMPOSITIONS CONTAINING A DGAT1 INHIBITOR | March 2020 | December 2021 | Allow | 20 | 1 | 1 | No | No |
| 16646891 | METHODS OF PREPARING COMPOSITIONS CONTAINING THYMOQUINONE | March 2020 | March 2022 | Allow | 24 | 0 | 1 | Yes | No |
| 16806703 | VETERINARY CANNABINOID, MENTHOL AND ANESTHETIC COMPOSITIONS AND METHODS | March 2020 | January 2022 | Allow | 23 | 1 | 0 | No | No |
| 16806333 | CANNABINOID AND ANESTHETIC COMPOSITIONS AND METHODS | March 2020 | December 2020 | Allow | 10 | 2 | 0 | Yes | No |
| 16805707 | All N 1 Summer Protection | February 2020 | February 2022 | Abandon | 23 | 2 | 0 | No | No |
| 16643418 | KELOID PREVENTION OR TREATMENT METHOD USING LIQUID PHASE PLASMA | February 2020 | September 2021 | Allow | 19 | 2 | 0 | No | No |
| 16802181 | HIGH-PRECISION DRUG DELIVERY BY DUAL-DOMAIN OCULAR DEVICE | February 2020 | July 2021 | Allow | 16 | 1 | 0 | No | No |
| 16873181 | AST-120 for non-systemic newborn and pediatric hyperammonemia therapy | February 2020 | April 2024 | Abandon | 50 | 7 | 0 | Yes | No |
| 16787673 | PREVENTING OR REDUCING PLANT GROWTH BY BIOCEMENTATION | February 2020 | July 2022 | Allow | 29 | 5 | 0 | Yes | No |
| 16637182 | WATER VAPOR SUPPRESSION MATERIAL AND PRODUCTION METHOD THEREFOR | February 2020 | October 2024 | Abandon | 56 | 2 | 1 | No | No |
| 16635481 | Multi-Mineral Supplement for Improved Bone Density | January 2020 | June 2022 | Abandon | 29 | 1 | 0 | No | No |
| 16748345 | ANTIMICROBIAL COLLOIDAL SILVER PRODUCTS AND METHOD OF MAKING SAME | January 2020 | June 2021 | Abandon | 16 | 1 | 0 | No | No |
| 16631377 | METHODS OF CONTROLLING OR PREVENTING INFESTATION OF SOYBEAN PLANTS BY PHYTOPATHOGENIC MICROORGANISMS | January 2020 | June 2021 | Allow | 17 | 2 | 0 | No | No |
| 16740007 | Trans-mucosal Delivery System for Testosterone | January 2020 | April 2023 | Allow | 39 | 5 | 0 | Yes | No |
| 16629897 | FIBRILLAR-PROTEIN BASED COMPOSITIONS AND USES THEREOF | January 2020 | October 2023 | Abandon | 45 | 4 | 0 | No | No |
| 16628476 | PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION | January 2020 | December 2022 | Allow | 36 | 3 | 0 | Yes | No |
| 16733072 | ORIENTED P4HB IMPLANTS CONTAINING ANTIMICROBIAL AGENTS | January 2020 | November 2020 | Allow | 10 | 1 | 0 | Yes | No |
| 16725667 | Modified Biological Control Agents and Their Uses | December 2019 | August 2022 | Allow | 31 | 1 | 0 | No | No |
| 16626194 | METHOD FOR TREATING FIBRILLAR COLLAGENOUS CONDITIONS | December 2019 | November 2021 | Allow | 23 | 2 | 0 | Yes | No |
| 16722167 | COMPOSITION AND METHOD FOR THE PREVENTION AND TREATMENT OF OBESITY | December 2019 | April 2020 | Allow | 4 | 0 | 0 | Yes | No |
| 16620674 | HIGH GLYCEROL COMPOSITION COMPRISING BLENDS OF ALKYL ISETHIONATE AND ALKYL TAURATE | December 2019 | February 2024 | Abandon | 51 | 4 | 0 | No | Yes |
| 16706142 | TOPICAL THERAPY FOR THE TREATMENT OF SKIN MALIGNANCIES USING NANOPARTICLES OF TAXANES | December 2019 | August 2020 | Allow | 9 | 1 | 0 | No | No |
| 16699307 | PREVENTION OF BOAR TAINT AND AGGRESSION | November 2019 | December 2021 | Abandon | 25 | 3 | 0 | No | No |
| 16618167 | RESORBABLE BIODEGRADABLE MEDICAL AND COSMETIC COMPOSITION COMPRISING POLY(1,3-TRIMETHYLENE CARBONATE) | November 2019 | January 2022 | Allow | 26 | 1 | 0 | Yes | No |
| 16618013 | CONTROLLABLE ION RELEASE CALCIUM PARTICLES, METHOD FOR PRODUCING SAME AND USE THEREOF | November 2019 | August 2022 | Allow | 32 | 1 | 1 | No | No |
| 16693422 | Photosensitive Dyes and Method of Using Said Dyes | November 2019 | March 2022 | Abandon | 27 | 2 | 0 | Yes | No |
| 16695001 | HYALURONIC ACID-BASED GELS INCLUDING LIDOCAINE | November 2019 | September 2020 | Allow | 10 | 1 | 0 | No | No |
| 16690558 | OXYGEN-GENERATING COMPOSITIONS FOR ENHANCING CELL AND TISSUE SURVIVAL IN VIVO | November 2019 | January 2022 | Allow | 26 | 4 | 0 | No | No |
| 16615148 | COMPOSITION FOR PREVENTING OR TREATING VISCERAL FAT OBESITY CONTAINING EXTRACT OF SALVIA MILTIORRHIZA RADIX | November 2019 | July 2021 | Abandon | 20 | 1 | 0 | No | No |
| 16688797 | ALCOHOL-RESISTANT DRUG FORMULATIONS | November 2019 | January 2022 | Allow | 26 | 3 | 0 | Yes | No |
| 16686799 | BUCKWHEAT HONEY AND BACITRACIN WOUND-HEALING DRESSING | November 2019 | September 2021 | Allow | 22 | 2 | 0 | No | No |
| 16687337 | HAIR TREATMENTS | November 2019 | October 2021 | Allow | 23 | 2 | 0 | No | No |
| 16613858 | USE OF NATURALLY GLYCOSYLATED POLYPHENOLS AS PROTECTIVE AGENTS AGAINST THE EFFECTS OF ULTRAVIOLET IRRADIATION | November 2019 | July 2022 | Allow | 32 | 3 | 0 | No | No |
| 16612868 | DEAD SEA SALTS COSMETIC COMPOSITIONS | November 2019 | July 2022 | Abandon | 32 | 4 | 0 | No | No |
| 16612128 | AROMATIC CULTURE PRODUCT OF MICROORGANISM | November 2019 | October 2021 | Allow | 24 | 2 | 0 | Yes | No |
| 16608907 | YARROW FRESH-PLANT PRESSED JUICE CONCENTRATE, PRODUCTION, AND USE | October 2019 | September 2021 | Allow | 23 | 2 | 0 | Yes | No |
| 16664698 | METHODS OF TREATMENT WITH MIXED METAL COMPOUND | October 2019 | July 2024 | Abandon | 57 | 4 | 1 | No | Yes |
| 16664227 | WOUND HEALING COMPOSITIONS AND METHODS OF USE | October 2019 | February 2020 | Allow | 4 | 0 | 0 | No | No |
| 16659186 | MODIFIED BIOLOGICAL CONTROL AGENTS AND THEIR USES | October 2019 | July 2021 | Abandon | 21 | 0 | 1 | No | No |
| 16493242 | METHODS OF TREATMENT OF HLA-B27 RELATED INFLAMMATORY DISEASES AND COMPOSITIONS RELATED TO SAME | September 2019 | July 2022 | Abandon | 34 | 2 | 0 | No | No |
| 16491374 | AEROSOL DEVICE FOR HAIR SHAPING AND/OR HAIRSTYLE HOLD | September 2019 | March 2022 | Allow | 31 | 3 | 0 | Yes | No |
| 16490657 | COMPOSITIONS AND METHODS FOR PROMOTING HEMOSTASIS | September 2019 | April 2021 | Abandon | 20 | 2 | 0 | No | No |
| 16555241 | VETERINARY CANNABINOID, MENTHOL AND ANESTHETIC COMPOSITIONS AND METHODS | August 2019 | December 2020 | Allow | 15 | 2 | 0 | Yes | No |
| 16488938 | COMPOSITION FOR DERMAL INJECTION | August 2019 | May 2021 | Allow | 21 | 0 | 0 | Yes | No |
| 16488848 | COSMETIC COMPOSITION FOR WRINKLE REDUCTION OR ANTI-INFLAMMATION, CONTAINING SUBSTANCE P | August 2019 | March 2023 | Abandon | 43 | 4 | 0 | No | No |
| 16484870 | DRUG DELIVERY FORMULATION FOR TREATING MENTAL ILLNESS OR CENTRAL NERVOUS SYSTEM DISORDER | August 2019 | February 2022 | Allow | 30 | 2 | 1 | No | No |
| 16536557 | Activation And Stabilization Of Basic Aluminum Chloride Solution By Zinc | August 2019 | January 2023 | Abandon | 41 | 2 | 0 | No | Yes |
| 16532699 | METHOD FOR TREATING INTESTINAL DISEASES PRESENTING AT LEAST ONE INFLAMMATORY COMPONENT | August 2019 | December 2020 | Abandon | 16 | 1 | 0 | No | No |
| 16526874 | CAT AND DOG STERILIZATION BY ESTROGENIC COMPOUNDS | July 2019 | June 2021 | Allow | 23 | 4 | 0 | Yes | No |
| 16525569 | HYALURONIC ACID BASED FORMULATIONS | July 2019 | March 2023 | Abandon | 44 | 6 | 0 | Yes | No |
| 16521547 | HYALURONIC ACID-BASED GELS INCLUDING LIDOCAINE | July 2019 | July 2021 | Allow | 24 | 3 | 0 | No | No |
| 16516167 | COMPOSITION AND METHOD FOR THE ALLEVIATION OF EFFECTS OF ALCOHOL CONSUMPTION | July 2019 | December 2020 | Abandon | 17 | 1 | 0 | No | No |
| 16460308 | METHOD OF TREATING A SKIN CONDITION | July 2019 | February 2022 | Allow | 32 | 3 | 0 | No | No |
| 16475397 | INSECT PEST CONTROL PRODUCT AND INSECT PEST CONTROL METHOD | July 2019 | May 2021 | Abandon | 23 | 2 | 0 | Yes | No |
| 16473927 | INSECT REPELLENT PRODUCT | June 2019 | May 2021 | Abandon | 23 | 3 | 0 | No | No |
| 16451967 | ENCAPSULATION OF METAL OXIDE NANOMATERIALS FOR CONTROLLED RELEASE AND TARGETED DELIVERY | June 2019 | June 2024 | Abandon | 60 | 6 | 1 | Yes | No |
| 16449431 | METHOD AND FORMULATION FOR TREATMENT OF WOUNDS BY NEW TISSUE REGENERATION WITH REDUCED TRAUMA AND SCAR TISSUE FORMATION | June 2019 | November 2023 | Abandon | 53 | 7 | 0 | Yes | No |
| 16471747 | OIL-IN-WATER EMULSION AND COSMETIC USE THEREOF | June 2019 | August 2022 | Allow | 38 | 4 | 0 | Yes | No |
| 16440557 | USE OF CICLESONIDE FOR THE TREATMENT OF RESPIRATORY DISEASES | June 2019 | September 2021 | Abandon | 27 | 2 | 0 | No | Yes |
| 16433660 | BISMUTH-THIOLS AS ANTISEPTICS FOR AGRICULTURAL, INDUSTRIAL AND OTHER USES | June 2019 | February 2021 | Abandon | 20 | 1 | 0 | No | No |
| 16422467 | ORAL COMPOSITION AND METHOD | May 2019 | November 2022 | Allow | 42 | 4 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SOROUSH, ALI.
With a 21.1% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 25.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner SOROUSH, ALI works in Art Unit 1617 and has examined 613 patent applications in our dataset. With an allowance rate of 45.2%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 35 months.
Examiner SOROUSH, ALI's allowance rate of 45.2% places them in the 10% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by SOROUSH, ALI receive 2.76 office actions before reaching final disposition. This places the examiner in the 77% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by SOROUSH, ALI is 35 months. This places the examiner in the 38% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +37.9% benefit to allowance rate for applications examined by SOROUSH, ALI. This interview benefit is in the 85% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 15.4% of applications are subsequently allowed. This success rate is in the 13% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 22.4% of cases where such amendments are filed. This entry rate is in the 31% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 88.9% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 68% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 67.2% of appeals filed. This is in the 53% percentile among all examiners. Of these withdrawals, 61.5% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 43.2% are granted (fully or in part). This grant rate is in the 34% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 0.5% of allowed cases (in the 59% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 0% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.